Ani Pharmaceuticals Inc

ANIP

Log in to follow and get free email alerts when insiders file.

Sector

Pharmaceutical Preparations

Industry

Drugs

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    0%0%

    $0.00

    avg. $0.00

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    0

    Filers

    0

    3 Month

    100%0%

    $49,815.84

    avg. $49,815.84

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    1

    Filers

    1

    12 Month

    81.7%18.3%

    $1.45M

    avg. $1.45M

    $325,754.89

    avg. $27,146.24

    Buy/Sell Ratio

    4.45


    Transactions

    15

    Filers

    14

    24 Month

    49.3%50.7%

    $1.01M

    avg. $1.01M

    $1.04M

    avg. $43,342.04

    Buy/Sell Ratio

    0.973


    Transactions

    42

    Filers

    35

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1819879Thoma Jeanne2021-12-222021-12-22
    1272247HAUGHEY THOMAS2021-12-072020-03-05
    1870913Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS2021-11-232021-11-23
    1871002Gassert ChadSVP - CORP. DEV. & STRATEGY2021-11-232021-11-23
    1822629Lalwani NikhilPRESIDENT & CEO2021-09-102020-09-10
    1579587Marken James G.SVP Ops & Prod Dev2021-04-132020-04-08
    1579464Schrepfer Robert WSVP - New Bus Dev & Spec Sales2021-03-292020-03-31
    1674236CAREY STEPHEN P.Vice President and CFO2021-03-252020-03-31
    1579672Brown Robert E. JR2021-03-252020-04-14
    1720568Walsh Patrick D2021-03-172020-04-14
    1846478Gutwerg OriSVP, GENERICS2021-02-172021-02-17
    1846487Mutz ChristopherCHIEF COMMERCIAL OFFICER2021-02-172021-02-17
    1251968NASH DAVID2020-04-142020-04-14
    1268135PRZYBYL ARTHURPresident and CEO2020-04-082020-03-31